AN2 Therapeutics Inc (ANTX)
2.555
+0.02
(+0.99%)
USD |
NASDAQ |
May 03, 11:23
AN2 Therapeutics Total Liabilities (Quarterly): 14.04M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.04M |
| September 30, 2023 | 14.84M |
| June 30, 2023 | 11.16M |
| March 31, 2023 | 8.567M |
| December 31, 2022 | 7.188M |
| Date | Value |
|---|---|
| September 30, 2022 | 4.435M |
| June 30, 2022 | 4.153M |
| March 31, 2022 | 5.093M |
| December 31, 2021 | 3.408M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.408M
Minimum
Dec 2021
14.84M
Maximum
Sep 2023
8.099M
Average
7.188M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 38.84B |
| QuidelOrtho Corp | 3.557B |
| CymaBay Therapeutics Inc (DELISTED) | 142.43M |
| Insmed Inc | 1.662B |
| Revance Therapeutics Inc | 630.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.74M |
| Shareholders Equity (Quarterly) | 124.70M |